vs

Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and Yatsen Holding Ltd (YSG). Click either name above to swap in a different company.

Yatsen Holding Ltd is the larger business by last-quarter revenue ($164.2M vs $93.1M, roughly 1.8× HIVE Digital Technologies Ltd.). Yatsen Holding Ltd runs the higher net margin — -0.5% vs -98.1%, a 97.6% gap on every dollar of revenue. Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs 24.5%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

Yatsen Holding Ltd is a leading China-based beauty and personal care group. It develops and sells cosmetics, skincare products and fragrances under brands including Perfect Diary, Little Ondine and Abby's Choice, with core markets in mainland China, Southeast Asia, targeting Gen Z and young adult consumers.

HIVE vs YSG — Head-to-Head

Bigger by revenue
YSG
YSG
1.8× larger
YSG
$164.2M
$93.1M
HIVE
Higher net margin
YSG
YSG
97.6% more per $
YSG
-0.5%
-98.1%
HIVE
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
24.5%
YSG

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
HIVE
HIVE
YSG
YSG
Revenue
$93.1M
$164.2M
Net Profit
$-91.3M
$-776.5K
Gross Margin
-27.1%
77.8%
Operating Margin
-34.0%
Net Margin
-98.1%
-0.5%
Revenue YoY
218.6%
Net Profit YoY
-234.0%
EPS (diluted)
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIVE
HIVE
YSG
YSG
Q4 25
$93.1M
$164.2M
Q3 25
$87.3M
$95.1M
Q2 25
$45.6M
$110.9M
Q1 25
$106.6M
Q4 24
$29.2M
$147.0M
Q3 24
$22.6M
$102.3M
Q2 24
$32.2M
$118.1M
Q1 24
$106.0M
Net Profit
HIVE
HIVE
YSG
YSG
Q4 25
$-91.3M
$-776.5K
Q3 25
$-15.8M
$-17.0M
Q2 25
$35.0M
$-11.9M
Q1 25
$-17.2M
Q4 24
$68.2M
$-67.7M
Q3 24
$80.0K
$-28.2M
Q2 24
$-18.3M
$-14.9M
Q1 24
$7.0M
Gross Margin
HIVE
HIVE
YSG
YSG
Q4 25
-27.1%
77.8%
Q3 25
4.7%
75.9%
Q2 25
-13.6%
76.7%
Q1 25
77.7%
Q4 24
-43.7%
73.7%
Q3 24
-66.1%
71.4%
Q2 24
-7.4%
74.7%
Q1 24
74.3%
Operating Margin
HIVE
HIVE
YSG
YSG
Q4 25
-34.0%
Q3 25
-20.9%
Q2 25
-17.0%
Q1 25
-20.4%
Q4 24
-50.3%
Q3 24
-32.2%
Q2 24
-15.7%
Q1 24
-0.9%
Net Margin
HIVE
HIVE
YSG
YSG
Q4 25
-98.1%
-0.5%
Q3 25
-18.1%
-17.9%
Q2 25
76.8%
-10.8%
Q1 25
-16.1%
Q4 24
233.2%
-46.1%
Q3 24
0.4%
-27.6%
Q2 24
-56.7%
-12.6%
Q1 24
6.6%
EPS (diluted)
HIVE
HIVE
YSG
YSG
Q4 25
$-0.38
Q3 25
$-0.07
Q2 25
$0.18
Q1 25
Q4 24
$0.52
Q3 24
$0.00
Q2 24
$-0.17
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIVE
HIVE
YSG
YSG
Cash + ST InvestmentsLiquidity on hand
$109.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$559.3M
$428.9M
Total Assets
$624.0M
$550.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIVE
HIVE
YSG
YSG
Q4 25
$109.4M
Q3 25
$97.0M
Q2 25
$133.1M
Q1 25
$92.3M
Q4 24
$40.5M
$112.0M
Q3 24
$31.7M
$71.7M
Q2 24
$109.6M
Q1 24
$179.9M
Stockholders' Equity
HIVE
HIVE
YSG
YSG
Q4 25
$559.3M
$428.9M
Q3 25
$624.6M
$423.1M
Q2 25
$560.5M
$431.5M
Q1 25
$422.2M
Q4 24
$430.9M
$418.1M
Q3 24
$275.5M
$516.0M
Q2 24
$268.6M
$519.4M
Q1 24
$551.6M
Total Assets
HIVE
HIVE
YSG
YSG
Q4 25
$624.0M
$550.1M
Q3 25
$693.0M
$564.8M
Q2 25
$628.7M
$564.4M
Q1 25
$534.3M
Q4 24
$478.6M
$544.0M
Q3 24
$334.7M
$635.6M
Q2 24
$635.8M
Q1 24
$662.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIVE
HIVE
YSG
YSG
Operating Cash FlowLast quarter
$46.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIVE
HIVE
YSG
YSG
Q4 25
$46.0M
Q3 25
$-10.6M
Q2 25
$10.2M
Q1 25
Q4 24
$-28.5M
Q3 24
$-2.2M
Q2 24
$-4.4M
Q1 24
Free Cash Flow
HIVE
HIVE
YSG
YSG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$-55.5M
Q3 24
$-34.7M
Q2 24
Q1 24
FCF Margin
HIVE
HIVE
YSG
YSG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-189.9%
Q3 24
-153.4%
Q2 24
Q1 24
Capex Intensity
HIVE
HIVE
YSG
YSG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
92.5%
Q3 24
143.9%
Q2 24
Q1 24
Cash Conversion
HIVE
HIVE
YSG
YSG
Q4 25
Q3 25
Q2 25
0.29×
Q1 25
Q4 24
-0.42×
Q3 24
-26.94×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons